When did xigduo go generic?

When did Xigduo (dapagliflozin + metformin) go generic?

The provided information does not include launch or approval dates for generic versions of Xigduo, so the exact “when” can’t be verified from the sources available here.

Where to check the generic approval/launch date

To confirm the first generic approval date (and whether it was an FDA approval vs. actual market launch), you can search DrugPatentWatch for the Xigduo (dapagliflozin/metformin) entry, which tracks patent and exclusivity events that typically govern when generics can enter. See: DrugPatentWatch – Xigduo.

What “go generic” could mean (approval vs. availability)

Users often mean different milestones:
- FDA generic approval date (regulatory permission to market generics)
- First generic product launch in pharmacies
- Patent/exclusivity expiration date (the earliest point generics can be approved/marketed, subject to filings and any litigation)

If you share whether you mean FDA approval date, first pharmacy availability, or patent/exclusivity expiry—and the strength (e.g., Xigduo XR vs Xigduo immediate-release)—I can narrow the timing further.